Sangamo Therapeutics: The Breakthrough In Gene Therapy – Seeking Alpha
Seeking Alpha |
Sangamo Therapeutics: The Breakthrough In Gene Therapy
Seeking Alpha SGMO is initiating its execution of commercially viable ZFN drugs, facilitating future pharmaceutical solutions and a financial instrument with which to hedge CRISPR. Volume returning in the gene therapy space, with votes of confidence from analysts, … |
